-
Economic Burden of Lung Cancer from the Perspective of a Brazilian Public Hospital
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients
Mar 10, 2025, 14:00 PM -
Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing
Mar 10, 2025, 14:00 PM -
A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?
Mar 10, 2025, 14:00 PM -
An AI-Powered RAG Based Framework for Data Extractions in Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Tripalimumab for Metastatic or Recurrent Triple-Negative Breast Cancer in Japan
Mar 10, 2025, 14:00 PM -
Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Mar 10, 2025, 14:00 PM -
Revascularization and Patency in Lower Limb Peripheral Arterial Disease: A Systematic Review and Meta-Analysis Comparing Paclitaxel-Eluting with Bare Metal Stents
Mar 10, 2025, 14:00 PM -
Dinutuximab BetaVersus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma - Matching-Adjusted Indirect Treatment Comparison and Economic Evaluation in Mexico
Mar 10, 2025, 14:00 PM -
The Role of Real-World Evidence in Breast Cancer Drug Submissions to NICE: Insights and Challenges
Mar 10, 2025, 14:00 PM -
Direct Costs of Pneumococcal Disease in the United States - A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM)
Mar 10, 2025, 14:00 PM -
What Does the Pan-Asian Evidence for Malignant Robotic-Assisted Procedures With da Vinci Surgical Systems Say? A systematic Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling.
Mar 10, 2025, 14:00 PM -
Prescribing Trends of Disease-Modifying Medications in Texas Medicaid Enrollees with Sickle Cell Disease
Mar 10, 2025, 14:00 PM -
Evaluating the Impact of Luxturna Gene Therapy on Vision Improvement and Disease Progression in Patients With RPE65 Mutation-Associated Inherited Vision Loss
Mar 10, 2025, 14:00 PM -
MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints
Mar 10, 2025, 14:00 PM
